Femasys (FEMY) had the highest return on September 28, 2023 by a US stock, returning 40.7%.

ASSET	DATE	% RETURN
Femasys (FEMY)	9/28/2023	40.74%
Aytu BioScience (AYTU)	9/28/2023	37.63%
Captivision (CAPT)	9/28/2023	30%
Soleno Therapeutics (SLNO)	9/28/2023	22.57%
Chanson International Holding Class A Ordinary Shares (CHSN)	9/28/2023	21.68%
Snow Lake Resources (LITM)	9/28/2023	21.36%
Frontier Nuclear and Minerals (FNUC)	9/28/2023	21.36%
Neuropace (NPCE)	9/28/2023	20.44%
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL)	9/28/2023	19.41%
XChange TECINC (XHG)	9/28/2023	18.38%
Mediwound (MDWD)	9/28/2023	17.77%
AmpliTech (AMPG)	9/28/2023	17.65%
TSS, Inc Common Stock (TSSI)	9/28/2023	17.33%
SAB Biotherapeutics (SABS)	9/28/2023	16.67%
Unicycive Therapeutics (UNCY)	9/28/2023	16.67%
NextTrip (NTRP)	9/28/2023	15.77%
Torrid (CURV)	9/28/2023	15.19%
Palladyne AI (PDYN)	9/28/2023	15%
Enveric Biosciences (ENVB)	9/28/2023	14.42%
Lifezone Metals (LZM)	9/28/2023	14.06%
Galecto (GLTO)	9/28/2023	13.99%
Damora Therapeutics (DMRA)	9/28/2023	13.99%
Beamr Imaging Ltd Ordinary Share (BMR)	9/28/2023	13.79%
Blend Labs (BLND)	9/28/2023	13.56%
Genasys (GNSS)	9/28/2023	13.19%